# Lomitapide

## Overview
Lomitapide is a medication primarily used to treat adults with homozygous familial hypercholesterolemia (HoFH), a genetic disorder characterized by extremely high levels of cholesterol in the blood. It works by inhibiting the microsomal triglyceride transfer protein (MTP), which plays a key role in the assembly and secretion of lipoproteins, thus reducing the production of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) cholesterol.

## Main Effects and Uses
- Reduces levels of LDL cholesterol in patients with HoFH.
- Aids in lowering total cholesterol and triglyceride levels in conjunction with a low-fat diet.
- Used as part of a comprehensive treatment plan that may include dietary management and other cholesterol-lowering therapies.

## Side Effects
### Serious Side Effects
- Liver damage (elevated liver enzymes)
- Fatty liver (hepatic steatosis)
- Gastrointestinal bleeding
- Gallbladder disease

### Other Side Effects
- Diarrhea
- Nausea
- Vomiting
- Abdominal pain
- Dyspepsia (indigestion)
- Flatulence
- Fatigue
- Headache
- Insomnia
- Rash

## Drug Interactions
Lomitapide should be used with caution in patients taking certain other medications, as it can interact with:
- Warfarin (increased bleeding risk)
- Statins (increased risk of myopathy or rhabdomyolysis)
- Other cholesterol-lowering medications (may enhance effects)
- Strong CYP3A4 inhibitors (increased risk of adverse effects)

It is prudent to discuss all medications, including over-the-counter drugs and supplements, with a healthcare provider before starting Lomitapide.